Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. NEU has two key drug products comprising NNZ-2566 and NNZ-2591. NEU has operations in New Zealand, Australia and the USA.
Neuren Pharmaceuticals Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.neurenpharma.com.
This a small cap company with market cap of 148 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how neu dividend grows in the recent years.